Company intelligence / Profile preview

Joyworks Network

South San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Joyworks Network is a biotechnology company focused on leveraging network biology and computational tools to discover novel therapeutic targets. Founded by former Denali Therapeutics executive Alexander Schuth, the company aims to decode complex disease biology to develop transformative medicines. Joyworks utilizes a proprietary platform to map cellular networks and identify key nodes for intervention in diseases with high unmet needs. The company is backed by leading life science investors and operates primarily in the pre-clinical stage. Its approach integrates high-dimensional biological data with machine learning to accelerate the drug discovery process.

Therapeutic areas: OncologyImmunologyNeurology
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Joyworks Network.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Joyworks Network.

Explore the full profile